Clinical Trial Update: Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GLS-010 Injection in Classical Hodgkin's Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• GLS-010 Injection

Snippet

Sponsor: Guangzhou Gloria Biosciences Co., Ltd. | Conditions: Classical Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN